Roquette to Acquire Qualicaps

French plant ingredients supplier Roquette, which is also is a leading player in naturally-derived pharmaceutical excipients, has agreed to acquire Qualicaps, a producer of hard capsules and pharmaceutical processing equipment for oral dosage.

The transaction is expected to close in the fourth quarter of 2023 but remains subject to the fulfillment of some customary and legal conditions. Financial details were not disclosed.

Qualicaps, part of Mitsubishi Chemical, is headquartered in Nara, Japan, and is the third largest producer of hard capsules for oral dosage solutions. The company has 1,400 employees located in sites in Asia, Europe and the Americas, and its client base includes major pharmaceutical and food companies around the world.

Roquette commented that this strategic investment offers the ability to expand the global footprint of its pharmaceutical business, as well as enrich its offerings of oral dosage solutions.

The newly combined businesses will offer the most diverse range of oral dosage solutions to existing and new customers, said Roquette.

Pierre Courduroux, CEO of Roquette, said: “Today’s announcement is a significant step in Roquette’s journey to reinforce its position as a key player in Health and Nutrition markets. Qualicaps’ strong position in hard capsules will represent a significant addition to our excipients’ portfolio and will enable our company to offer more solutions responding to the needs of our customers and to the demands of patients who are looking for continuously better treatments.”

Roquette has agreed to acquire Qualicaps, a producer of hard capsules and...
Roquette has agreed to acquire Qualicaps, a producer of hard capsules and pharmaceutical processing equipment for oral dosage. © Roquette

Virtual Event

Digitalization in the Chemical Industry
CHEManager Spotlight

Digitalization in the Chemical Industry

Save the Date: October 22, 2025
The event will be promoted to a combined audience of over 100,000 professionals across Europe through the CHEManager and CITplus networks.

Whitepaper

Excellence in Pharmaceutical Distribution and The Critical Role of Good Distribution Practice (GDP)
Setting the Standard

Excellence in Pharmaceutical Distribution and The Critical Role of Good Distribution Practice (GDP)

Are you ready to elevate your pharmaceutical operations? Download our exclusive whitepaper and discover how compliance with Good Distribution Practice (GDP) is essential for the safety and integrity of pharmaceuticals.

most read

Photo
21.03.2025 • News

What’s Next for Pharma Supply Chains?

Sudden shifts in demand, supply shortages and global collapse have put immense pressure on pharmaceutical logistics. To address these challenges, PHARMAP 2025 brings together industry experts to discover AI-driven supply chain optimisation, strategic logistics partnerships and digital solutions that enhance efficiency and resilience in the pharmaceutical supply chain.